Beigene Ltd
SSE:688235

Watchlist Manager
Beigene Ltd Logo
Beigene Ltd
SSE:688235
Watchlist
Price: 181.96 CNY 6.41% Market Closed
Market Cap: 247.2B CNY
Have any thoughts about
Beigene Ltd?
Write Note

Relative Value

The Relative Value of one Beigene Ltd stock under the Base Case scenario is 280.38 CNY. Compared to the current market price of 181.96 CNY, Beigene Ltd is Undervalued by 35%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
280.38 CNY
Undervaluation 35%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
72
vs Industry
49
Median 3Y
14.2
Median 5Y
14.2
Industry
7.9
Forward
9.8
vs History
vs Industry
Median 3Y
-15.2
Median 5Y
-15.2
Industry
23.3
Forward
-53.2
vs History
vs Industry
Median 3Y
-21.2
Median 5Y
-21.2
Industry
22.8
vs History
vs Industry
Median 3Y
-16.8
Median 5Y
-16.8
Industry
26.4
vs History
2
vs Industry
12
Median 3Y
6.4
Median 5Y
6.4
Industry
2.6
vs History
69
vs Industry
43
Median 3Y
12.6
Median 5Y
12.6
Industry
7.6
Forward
9.3
vs History
69
vs Industry
39
Median 3Y
15.3
Median 5Y
15.3
Industry
9
vs History
vs Industry
Median 3Y
-14.5
Median 5Y
-14.5
Industry
4.7
Forward
-56.2
vs History
vs Industry
Median 3Y
-14.5
Median 5Y
-14.5
Industry
4.3
Forward
-47.1
vs History
vs Industry
Median 3Y
-18.2
Median 5Y
-18.2
Industry
6.4
vs History
vs Industry
Median 3Y
-13.3
Median 5Y
-13.3
Industry
4.2
vs History
22
vs Industry
20
Median 3Y
10.2
Median 5Y
10.2
Industry
4.7

Multiples Across Competitors

Competitors Multiples
Beigene Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KY
Beigene Ltd
SSE:688235
243B CNY 11 -55.6 -34.4 -34.4
US
Abbvie Inc
NYSE:ABBV
333B USD 6.1 62.9 15.4 23.6
US
Amgen Inc
NASDAQ:AMGN
172.6B USD 5.6 55.1 19.5 35.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
128.7B USD 12.4 -262.7 28 29.4
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
110.9B USD 8.2 25.7 22.3 24.7
US
Gilead Sciences Inc
NASDAQ:GILD
108.9B USD 3.9 103.4 9.8 12.4
US
Epizyme Inc
F:EPE
94.1B EUR 1 923 -490.7 -534.4 -520.1
AU
CSL Ltd
ASX:CSL
145.8B AUD 6.6 37 22.6 28.1
US
Seagen Inc
F:SGT
39.3B EUR 18.5 -56.8 -61.1 -55.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
38B USD 16.2 -521.2 230.2 354.4
NL
argenx SE
NASDAQ:ARGX
32.5B USD 16.7 -117.4 -93.5 -68.1
P/E Multiple
Earnings Growth
KY
Beigene Ltd
SSE:688235
Average P/E: 56.8
Negative Multiple: -55.6
N/A
US
Abbvie Inc
NYSE:ABBV
62.9
406%
US
Amgen Inc
NASDAQ:AMGN
55.1
74%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -262.7
38%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
25.7
56%
US
Gilead Sciences Inc
NASDAQ:GILD
103.4
71%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -490.7 N/A
AU
CSL Ltd
ASX:CSL
37
64%
US
S
Seagen Inc
F:SGT
Negative Multiple: -56.8 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -521.2 N/A
NL
argenx SE
NASDAQ:ARGX
Negative Multiple: -117.4 N/A
EV/EBITDA Multiple
EBITDA Growth
KY
Beigene Ltd
SSE:688235
Average EV/EBITDA: 49.7
Negative Multiple: -34.4
N/A
US
Abbvie Inc
NYSE:ABBV
15.4
28%
US
Amgen Inc
NASDAQ:AMGN
19.5
64%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
28
37%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
22.3
53%
US
Gilead Sciences Inc
NASDAQ:GILD
9.8
9%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -534.4 N/A
AU
CSL Ltd
ASX:CSL
22.6
42%
US
S
Seagen Inc
F:SGT
Negative Multiple: -61.1 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
230.2
N/A
NL
argenx SE
NASDAQ:ARGX
Negative Multiple: -93.5 N/A
EV/EBIT Multiple
EBIT Growth
KY
Beigene Ltd
SSE:688235
Average EV/EBIT: 72.6
Negative Multiple: -34.4
N/A
US
Abbvie Inc
NYSE:ABBV
23.6
88%
US
Amgen Inc
NASDAQ:AMGN
35.3
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
29.4
44%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
24.7
54%
US
Gilead Sciences Inc
NASDAQ:GILD
12.4
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -520.1 N/A
AU
CSL Ltd
ASX:CSL
28.1
55%
US
S
Seagen Inc
F:SGT
Negative Multiple: -55.1 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
354.4
N/A
NL
argenx SE
NASDAQ:ARGX
Negative Multiple: -68.1 N/A

See Also

Discover More
Back to Top